2/11
08:51 am
spro
Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy [Seeking Alpha]
Medium
Report
Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy [Seeking Alpha]
1/24
05:10 am
spro
Spero Therapeutics (NASDAQ:SPRO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
Spero Therapeutics (NASDAQ:SPRO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/11
01:03 am
spro
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at
Wall Street
Low
Report
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at
Wall Street
1/3
01:08 am
spro
Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at
Wall Stre
Low
Report
Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at
Wall Stre
12/19
08:35 am
spro
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis [Yahoo! Finance]
Low
Report
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis [Yahoo! Finance]
12/19
08:00 am
spro
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
Low
Report
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
12/15
05:41 am
spro
Is Spero Therapeutics (NASDAQ:SPRO) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Low
Report
Is Spero Therapeutics (NASDAQ:SPRO) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
12/14
01:27 am
spro
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at
Wall Street
Low
Report
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at
Wall Street